SMXAX
Price
$18.89
Change
-$0.14 (-0.74%)
Updated
Sep 20 closing price
VSEMX
Price
$221.46
Change
-$1.60 (-0.72%)
Updated
Sep 20 closing price
Ad is loading...

SMXAX vs VSEMX

Header iconSMXAX vs VSEMX Comparison
Open Charts SMXAX vs VSEMXBanner chart's image
SEI Extended Market Index A (SIIT)
Price$18.89
Change-$0.14 (-0.74%)
VolumeN/A
CapitalizationN/A
Vanguard Extended Market Index Instl Sel
Price$221.46
Change-$1.60 (-0.72%)
VolumeN/A
CapitalizationN/A
View a ticker or compare two or three
SMXAX vs VSEMX Comparison Chart
Loading...
VS
SMXAX vs. VSEMX commentary
Sep 21, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is SMXAX is a Buy and VSEMX is a StrongBuy.

FUNDAMENTALS
Fundamentals
VSEMX has more cash in the bank: 107B vs. SMXAX (1.16B). VSEMX pays higher dividends than SMXAX: VSEMX (1.23) vs SMXAX (1.10). SMXAX was incepted earlier than VSEMX: SMXAX (12 years) vs VSEMX (8 years). SMXAX is a more actively managed with annual turnover of: 34.00 vs. VSEMX (11.00). SMXAX has a lower initial minimum investment than VSEMX: SMXAX (100000) vs VSEMX (3000000000). SMXAX (28.09) and VSEMX (27.60) have marching annual gain over last year. VSEMX return over 5 years is better than : 55.80 vs. SMXAX (28.07).
SMXAXVSEMXSMXAX / VSEMX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence12 years8 years-
Gain YTD11.90010.700111%
Front LoadN/AN/A-
Min. Initial Investment10000030000000000%
Min. Initial Investment IRAN/AN/A-
Net Assets1.16B107B1%
Annual Yield % from dividends1.101.2390%
Returns for 1 year28.0927.60102%
Returns for 3 years-15.87-0.632,525%
Returns for 5 years28.0755.8050%
Returns for 10 years66.55N/A-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
OCTO2.610.42
+19.17%
Eightco Holdings Inc
UFI7.700.11
+1.45%
UNIFI
ALKT31.64-0.41
-1.28%
Alkami Technology
BXP81.02-1.29
-1.57%
BXP Inc.
TRDA14.69-0.31
-2.07%
Entrada Therapeutics